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Abstract
Background: Many pharmacological and nonpharmacologic therapies are available for the treatment of the low back pain (LBP). Despite
medications are the most frequently prescribed therapy for LBP, the use of various complementary medicine techniques is increasing. The paper
summarizes the latest evidence on the treatment of musculoskeletal conditions (with special focus on chronic LBP) by using acupuncture and bee
venom therapy (BVT).
Methodology: The overview is based on English-language studies and articles found by searches of Medline over more than last 10 years. All the
paper found that refer to LBP and at least one of the analyzed therapies have been taken into account.
Results: The mechanism of action, efficiency, harms, toxicity and contraindications are highlighted for the two therapies. The literature on these
topics is extensive and controversial. There are trials in favour of using the two complementary therapies for rheumatic diseases, as well trials
arguing that the observed analgesic effects are related to a strong placebo response.
Conclusions: The choice of using acupuncture and BVT for chronic LBP depends on various factors related to patient features and preferences,
but nowadays an increased attention and support has to be noted.
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Introduction
The chronic low back pain (CLBP) represents a major health problem having high social impact, characterized by important costs and
economics losses, but also an important suffering source in individual plan (Chenot et al., 2007). In the industrialized countries, back pain affects
between 15% and 30% of the population and generates high costs (Chou and Huffman, 2007). There are many therapeutic treatments available,
but is unclear from the literature which intervention is the most effective in treating nonspecific LBP, which represent about 90% from total cases
of LBP (Hutchinson et al., 2012).
Acupuncture
Acupuncture has been successfully incorporated into medical or allied health practices in Western countries. As a means of treatment, in
China has been in use for about 3000 years. In its classical definition, acupuncture prevents and treats disease by the painless insertion of needles
at certain key points in the patient's body. Within the context of acupuncture, it is accepted that these points are part of a system and are connected
by channels, or meridians (Motl, 2002).
Acupuncture focuses on a holistic, energy-based approach to the patient, rather than a disease-oriented diagnostic and treatment model. When
integrated with Western-based Medicine, acupuncture is a very practical discipline, with a wide range of clinical applications, from pain
management problems to functional disturbances (Fargas-Babjak, 2004). Acupuncture is thought to have a general homeostatic effect, facilitating
the activity of the body’s natural healing mechanisms, thus returning the body to its normal functional state. When used for the therapeutic
purpose, it modulates the abnormal activity of the nervous system and/or of its associated effectors, the endocrine and exocrine systems.
Even though considerable scientific bases have been proven, the mechanisms of action of acupuncture in terms of Western scientific
principles have not been completely revealed, including in the case of chronic low back pain (Ammendolia et al., 2008). There are used two most
common models for the acupuncture mechanisms of action: the standard neurophysio-logical model and the gate-control model. In the first one,
the analgesic effects of acupuncture are at least partially explained by the actions of the opioid peptides (-endorphin, enkephalin, endomorphin,
and dynorphin) (Chou et al, 2012; Han, 2003) as well as hormones such as adrenocortico-trophin (ACTH) and cortisone (Carlsson, 2002), which
are released during acupuncture.
The gate-control theory of pain introduced first by Melzack and Wall (1965) explains the observed pain-relief resulting from stimulation of
somatic afferent nerves. The wide-dynamic-range neurones, located in the dorsal horn, receive input from both nociceptive and non-nociceptive
afferents and are inhibited by interneurones that are excited by non-noxious inputs in the same segment. This mechanism only explains pain relief
during stimulation and it does not explain why pain inhibition may outlast the duration of stimulation by hours or even days (Carlsson, 2002).
In the segmental acupuncture (needles are inserted within the segment of pain) the physiology is related to the spinal gate-control mechanism
(involving enkephalin and dynorphin). In the extra-segmental acupuncture the hypothalamus and the pituitary gland may be activated -
periaqueductal grey, and the descending pain relieving system (involving endorphins, serotonin and noradrenaline) (Price and Meyer, 1995) -
resulting in a broad spectrum of systemic effects. There are also claimed to be involved the diffuse noxious inhibitory control (Bing et al., 1990)
and/or the activation of the hypothalamic pituitary-adrenal (HPA)-axis with increased levels (in the blood) of β-endorphin and ACTH/ cortisone 
(Pomeranz, 2000; Han, 1987).
More recently the promising new researches utilizing functional magnetic resonance imaging seem to indicate the connection of the
autonomic nervous system with acupuncture through the inflammatory reflex, which regulates the immune system in the organism (Lin and Chen,
2008).
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The most successful applications of acupuncture are reported in acute and chronic musculoskeletal pain. Pain problems responsive to
acupuncture include: acute sprains and strains, pain from nerve entrapment, repetitive strain disorders (e.g. carpal tunnel syndrome, tennis elbow,
plantar fasciitis, Achilles tendonitis), myofascial pain patterns (e.g. tempero-mandibular joint pain, muscle tension headaches, shoulder pain, neck
and back pain), arthralgias (particularly osteoarthritic in nature), degenerative disc disease with or without radicular pain, pain following surgical
intervention (both musculo-skeletal and visceral), post herpetic neuralgia, peripheral neuropathic pain and miscellaneous headaches (Fargas-
Babjak, 2004).
In CLBP, a report done by Staud (2007) concludes that is strong evidence favouring the acupuncture short-term analgesic effectiveness
compared with most other therapies. The data analysed by Furlan et al. (2008) suggest also that acupuncture may be useful adjunct to other
therapies for CLBP. More, the acupuncture effects on CLBP pain seem to last for up to 2 years (Thomas et al, 2005). On the opposite, in the
treatment of acute low back pain, acupuncture data are considered still sparse and inconclusive (Staud, 2007).
Acupuncture toxicity and harms
Acupuncture is generally considered safe, harmless and non-toxic. But, as the effectiveness of acupuncture remains still controversial because
the mechanisms of action are not completely revealed, the lack of side effects is another issue for disputes.
There are several methods to do acupuncture. The standard or traditional acupuncture means the insertion of acupuncture needles into the
meridian points, while the patient is supposed to experience a sensation known as De-qi. Starting from this, new forms of acupuncture have been
developed, such as ear (auricular) acupuncture, head (scalp) acupuncture, hand acupuncture and foot acupuncture (Lao, 1996). Acupuncture
commonly includes manual stimulation of the needles, but various adjuncts are often used, including electrical acupuncture (in which an electrical
stimulator is connected to the acupuncture needle), injection acupuncture (herbal extracts injected into acupuncture points), heat lamps, and
acupuncture with moxibustion (the moxa herb, Artemisia vulgaris, is burned at the end of the needle) (Yanashita et al., 2000). So, the possible
acupuncture toxicity depends on the applied method. The techniques using dry needles are considered without toxicity, while the wet (injection)
acupuncture assumes the toxicity of the injected substance.
Acupuncture, as any intervention on the body, cannot be harmless. Impressive number of studies, case reports, surveys and prospective
studies has been dedicated to the safety of the acupuncture treatments. There are two kinds of approaches: the believers in acupuncture, which
consider this treatment near “harmless” and the sceptical ones that try to definitive demolish the “harmless myth”. Literature brought evidence for
all kind of adverse effects, from the less significant up to severe adverse reactions, even death.
The most recorded systemic reactions in individual patients were: tiredness, drowsiness, aggravation of pre-existing symptoms, itching in the
punctured regions, dizziness or vertigo, feeling of faintness or nausea during treatment, vomiting, headache and chest pain. Low incidence rate of
the recorded local reactions (minor bleeding on withdrawal of the needle, pain on insertion of the needle, petechia or ecchymosis; pain or ache in
the punctured region after the treatment; subcutaneous haematoma; pain or discomfort in the punctured region during the needle retention) has
been found by Yanashita et al. (2000).
Types of complications included infections (primarily hepatitis from a few practitioners), and organ, tissue, and nerve injury (Lao et al.,
2003). Serious adverse effects including pneumothorax, spinal lesions, and hepatitis B transmission have been reported in the literature, but these
are rare and generally associated with poorly trained unlicensed acupuncturists (Vickers et al., 2002).
In a comprehensive study, Ammendolia (2008) identified twelve trials reported complications or side effects related to acupuncture for CLBP.
These all were of a minor nature and most involved local bleeding or hematoma, the reported rate being between 6 and 8% of the patients.
Among the main withstanders of the myth “acupuncture is harmless”, Erik Ernst (2010) done a kind of systematically review of previous
systematically reviews, and found up to 86 instances of deaths after acupuncture. The most frequent causes of death were pneumothorax, various
types of (mostly bacterial) infections and accidental puncture of organs like heart, liver or large blood vessel, as well of the central nervous
system. The majority of cases happened in China or other Asian countries, at least some of these might have been avoided by better training in
anatomy and infection control.
Among all acupuncture associated complications, transmission of pathogenic microorganisms is one of the most important (Woo et al., 2010).
Few decades ago, the majority of the infections associated with acupuncture were sporadic cases of pyogenic bacterial infections, mainly due to
Staphylococcus aureus, as well as apparitions of hepatitis B virus infections. Although, the use of single-use or single-person needles led to a
lower incidence of blood borne viruses transmitted by acupuncture. Nevertheless, in 2009, there were first reports of methicillin resistant
Staphylococcus aureus transmitted by acupuncture (Woo, 2011).
Acupuncture is not recommended for patients who have haemophilia, bleeding disorders, and septicaemia, or those with cellulitis, local skin
infections, or loss of skin integrity from burns or ulcerations in the case of needling. Extra care should be taken for individuals who are pregnant,
have metal allergies, or are taking anticoagulant drugs (Sierpina and Frenkel, 2005).
Bee venom therapy
Among the bee products, the bee venom has the largest therapeutic area. The bee venom therapy (BVT) gained an increased interest in the last
decades. Bee venom is administered in the form of a direct bee sting or else by injection of a venom extract, and requires the expertise of a
qualified health care professional. Bee venom has been reported to have a central analgesic mechanism and a peripheral analgesic mechanism
along with a peripheral analgesic action from an anti-inflammatory effect through specific mechanisms (Shin et al., 2012).
When the bee venom is injected into acupuncture points (acupoint), the method calls bee venom acupuncture (BVA), which was proven
successful for producing a strong therapeutic effect as compared to injection in the non-acupoint areas (Kwon et al., 2001). In BVA the
mechanical effect from the stimulation of the acupuncture point has a supplementary action beside the pharmacological effect from the bioactive
bee venom compounds (Lee et al., 2005). On the other side, compared to classical acupuncture treatment, BVA is considered superior due to the
additional pharmacological effect of bee venom (Lee at al., 2008).
Bee venom composition and proprieties
Bee venom contains more than 18 different compounds that all possess pharmaceutical properties. Bee venom is a complex mixture of
proteins, peptides and low molecular components. The composition of fresh and dried bee venom differs mainly in regards to the volatile
components, but the overall biological activity remains similar (Bogdanov, 2014).
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The main components of the bee venom are the enzymes (proteins catalyzing specific reactions, as Phospholipase A2, Phospholipase B and
Hyalyronidase etc.) and peptides (Melittin, Apamine, MCD peptide, Procamine etc.). Beside these, bee venom contains smaller quantities of low
molecular compounds that are different in nature: amino acids, catecholamines (Histamine, Dopamine and Noradrenalin), sugars and minerals
(Ca, Mg, P).
The analgesic, anti-inflammatory, anti-cancer, and immuno-stimulant effects have been proven in numerous studies with animals (Huh et al.,
2010; Kim et al., 2008; and others). Several studies have reported also radio-protective and anti-mutagenic effects of bee venom, both in vitro and
in vivo (Hassanein and Hegab, 2010).
Bee Venom Therapy stimulates the immune system through the hypothalamus, pituitary and adrenal glands. As consequence, the body
produces its own healing agents. The healing mechanism is not completely revealed, but ongoing research has identified a number of naturally
occurring chemical compounds, which appear to work together in the body. One possible explanation of the anti-inflammatory effects is the
contribution to the production of endogenous plasma cortisol in the human body. Unlike the synthetic cortisone this has no side effects and plays
an important role in the regulation of lymphocyte numbers as well exert their effect on stressful task performance via modulation of the amygdala
(Sarria, 2012; Kwon et al., 2003).
Melittin, a polypeptide occupying over 50% of the whole honeybee venom, plays a central role in production of local inflammation,
nociception and hyperalgesia or allodynia (Chen, 2006). Melittin suppress inflammation by inhibiting enzymatic activity, an enzyme that is
abundantly released in severe inflammatory disorders and causes tissue and organ degradation (Mihelich and Schevitz, 1999).
Amongst the most important of the bee venom components seems to be the mast cell degranulating peptide (MCD) peptide, known also as
Peptide-401. Banks (1976) demonstrates that MCD peptide is 100 times more potent than hydrocortisone in the rat paw edema test. It is also a
better inhibitor than aspirin of the conversion of arachidonic acid to PE2.
Moreover, bee venom contains a variety of bioamines, such as apamin, dopamine (helps increasing motor activity), histamine, procamine,
serotonin, which facilitate nerve transmission and healing in a variety of nerve disorders. Adolapin, also a neurotransmitter, is a strong anti-
inflammatory substance with analgesic activity as well. Apamin enhances long term synaptic transmission by significantly inhibiting the activity
of C3 complement, and blocks calcium-dependent potassium channels. This gives bee venom the ability to travel along the neural pathways from
the spine to various trigger points and injured areas to help repair nerve damage and restore mobility (Rakha, 2013).
Compound X, hyaluronidase, phospholipase A2, histamine, and MCD peptide, are also involved in the inflammatory response of venom, with
softening of tissue and facilitation of flow of other beneficial substances to damaged areas of nervous tissue (Mraz, 2001).
The bee venom's anti-inflammatory effect is dependent on peripheral nerve integrity. Through a transection of the sciatic nerve, Kwon et al.
(2006) showed that the anti-inflammatory effect completely disappears, being not a locally mediated anti-inflammatory effect.
In the last decades a lot of scientific articles brought sound evidence of the effectiveness of bee venom against arthritis and painful
inflammatory conditions. BVT, due to the anti-inflammatory and analgesic effects, have been used for the treatment of different rheumatic
diseases as low back pain, neck pain, disc pain, herniated lumbar pain, rheumatoid arthritis etc. The evidence of effectiveness of the BVA in the
musculoskeletal pain management was analyzed and positive concluded by Lee et al. (2008) in a comprehensive review.
Bee venom toxicity and allergic reactions
Based upon all the literatures, there should be no strong objections to the use of bee venom. Actually, the great majority of authors who
address themselves to the effects of apitherapy report little undesirable reactions, as long as the patient is not allergic to bee venom (Kim, 1997).
Bee venom treatment did not affect motor activity, intestinal peristaltic function or gastric function. Additionally, bee venom did not alter blood
pressure and heart rate in rats nor respiratory rates in rabbits (Kim et al., 2004)
Usually, bee venom is administered in the form of a direct bee sting or else by injection of a venom extract, and the treatment starts with
testing the patient for allergy, which is known to occur in 1% of the general population (Mahmoud, 2012). A study done by Castro et al. (2005)
confirmed that the administration of repeated injections of bee venom in a step-up dosage regime, in non–bee venom allergic patients with
multiple sclerosis, had no serious adverse allergic reactions.
The bee venom is safe for human treatments, the median lethal dose (LD50) for an adult human being 2.8 mg of venom per kg of body
weight. Assuming a bee injects up to 0.3 mg venom per sting, results that a person could resist normally to hundreds of bee stings, depending on
its weight. Statistics shown most human deaths result from one or few bee stings due to allergic reactions, heart failure or suffocation from
swelling around the neck or the mouth (Mahmoud, 2012).
In getting the desensitization, the venom immunotherapy may be responsible for local and systemic allergic reactions. Purified aqueous and
purified aluminium hydroxide adsorbed extracts have the potential to reduce the incidence of venom immunotherapy side effects (Bilò et al.,
2010).
Few reports have claim severe toxicities developing in response to bee venom therapy (Park et al., 2010; Mytas et al., 2009). Hemo-
concentration can appear due to bee sting and might be related to the marked edema induced by the venom. Increase in various cytokines like
interleukin (IL)-1β, IL-6, tumour necrosis factor-α, etc. have been reported after bee sting.  
If just few stings are considered safe for non-allergic persons, mass inoculation of bee venom may induce acute renal failure, adult respiratory
distress syndrome, liver injury, cardiac damage, pancreatitis, skin necrosis, shock hypertension, bleeding, thrombocytopenia, and rhabdomyolysis
(Kluwer, 2009).
Discussion
The personal research done by authors has conclusions not far from the ones from literature. Regarding effectiveness, in a comparative study
on the efficiency of acupuncture vs. diclofenac (Author, 2013), the authors found statistically significant different but moderate-better results in
favour of the discussed complementary therapy. This is similar to Kaptchuk (2010) which found out that the recent scientific evidence for
acupuncture and CLBP has not been as spectacular as the majority of acupuncture practitioners claim.
In the absence of health assurance reimbursements, the complementary therapies need more time consumption and are usually costlier than
the simply medication. Between the explanations of the efficiency and attractiveness of the complementary and alternative could be, as Cherkin et
al. (2001) mentioned, the longer time spent by patient (up to one hour) in a relaxed environment, the ongoing attention and the therapeutic
touching. Also, acupuncture might enhance mental health independent on its effects on the physical health and BVT improves neurotransmission
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and facilitates repairing of tissue areas. The people that prefer this kind of treatment either are allergic to the drugs administration or pursue
complementary benefic effects from the complementary therapies.
Regarding harms and toxicity, the complementary therapies are considered less invasive than long cures with medication. The main worry and
caution is related to the bee venom toxicity that can be immediate or can manifest itself only weeks after the exposure. A case of hepatotoxicity at
three weeks after BVT for was reported by Alqutub et al. (2011). The authors experienced a quite similar experience with a 36-year-old female
that suffered a major unexpected anaphylactic shock in the sixth treatment session of BVT for CLBP.
Conclusion
The paper makes an up-to-date short review on the main stream literature found on Medline regarding acupuncture and BVT for the CLBP.
Although the results of the studies and trials remain still controversial regarding the efficiency, although toxicity potential could be important for
certain patients or harm potential exist because of untrained and inexperienced practitioners, both analyzed complementary therapies are taken
into consideration as ones of the cost-efficient alternatives procedures in CLBP treatment. It is important to keep in mind that, these are not
necessary a substitution variant for the pharmaceutical treatment and can be mixed with the last one in the patient benefit.
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